Proloterapinin Sekonder ve İyatrojenik Etkileri

Hacı Ahmet Aydemir

doi:10.53445/batd.1287712

TR EN

Proloterapinin Sekonder ve İyatrojenik Etkileri

Abstract

Proloterapi, biyolojik maddelerin enjekte edilerek lokal inflamatuar iyileşme sürecini başlatmayı hedefleyen rejeneratif bir tedavi uygulamasıdır. Son zamanlarda birçok hastalığın tedavisine yönelik yaygın kullanım alanı bulan proloterapi uygulamasına bağlı gözlemlenen bazı yan etkiler literatürde sunulmuştur. Bu derlememizde proloterapi uygulaması ile ilişkili uygulamada dikkat edilmesi gereken hususlar, yan etkiler ve kontrendikasyon durumları genel olarak incelenmiştir. Genel olarak proloterapi, yan etki profili ve kontrendikasyonlar açısından diğer enjeksiyon yöntemleri ile benzerlik göstermekte, ancak, uygulamayı yapan kişinin tecrübesi ve uygulamada rehber bir görüntüleme yöntemi kullanılmasının yan etkilerin azalmasına yardımcı olacağı öngörülmektedir

Keywords

Proloterapi, Yan Etki, Kontrendikasyon, Tamamlayıcı Tıp

References

Alderman, D. (2007). Prolotherapy for low back pain. Practical Pain Management, 7(4), 58-63.
Arias-Vázquez, P. I., Tovilla-Zárate, C. A., Castillo-Avila, R. G., Legorreta-Ramírez, B. G., López-Narváez, M. L., Arcila-Novelo, R., & González-Castro, T. B. (2022). Hypertonic Dextrose Prolotherapy, an Alternative to Intra-Articular Injections With Hyaluronic Acid in the Treatment of Knee Osteoarthritis: Systematic Review and Meta-analysis. Am J Phys Med Rehabil, 101(9), 816-825. doi: 10.1097/phm.0000000000001918
Bertrand, H., Reeves, K. D., Bennett, C. J., Bicknell, S., & Cheng, A. L. (2016). Dextrose Prolotherapy Versus Control Injections in Painful Rotator Cuff Tendinopathy. Arch Phys Med Rehabil, 97(1), 17-25. doi: 10.1016/j.apmr.2015.08.412
Catapano, M., Zhang, K., Mittal, N., Sangha, H., Onishi, K., & de Sa, D. (2020). Effectiveness of Dextrose Prolotherapy for Rotator Cuff Tendinopathy: A Systematic Review. Pm r, 12(3), 288-300. doi: 10.1002/pmrj.12268
Çakmak, S. (2017). Kas-iskelet sistemi hastalıklarında proloterapi. Totbid Dergisi, 16, 282-286.
Dagenais, S., Caro, J., & Haldeman, S. (2008). A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J, 8(1), 8-20. doi: 10.1016/j.spinee.2007.10.005
Dagenais, S., Ogunseitan, O., Haldeman, S., Wooley, J. R., Zaldivar, F., & Kim, R. C. (2006). Acute toxicity pilot evaluation of proliferol in rats and swine. Int J Toxicol, 25(3), 171-181. doi: 10.1080/10915810600683218
Dagenais, S., Yelland, M. J., Del Mar, C., & Schoene, M. L. (2007). Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev, 2007(2), Cd004059. doi: 10.1002/14651858.CD004059.pub3
Eroğlu, A., Aylin, S., & Durmuş, B. (2016). Platelet-rich plasma vs prolotherapy in the management of knee osteoarthritis: randomized placebo-controlled trial. Spor Hekimliği Dergisi, 51(2), 034-043.
Farpour, H. R., & Fereydooni, F. (2017). Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: A randomized clinical trial. Electron Physician, 9(11), 5663-5669. doi: 10.19082/5663

Geukens, J., Rabe, E., & Bieber, T. (1999). Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol, 9(2), 132-133.
Hakala, R. V. (2005). Prolotherapy (proliferation therapy) in the treatment of TMD. CRANIO®, 23(4), 283-288.
Hakala, R. V., & Ledermann, K. M. (2010). The use of prolotherapy for temporomandibular joint dysfunction. J Prolotherapy, 2(3), 439-446.
Hauser, R. A., & Sprague, I. S. (2014). Outcomes of prolotherapy in chondromalacia patella patients: improvements in pain level and function. Clin Med Insights Arthritis Musculoskelet Disord, 7, 13-20. doi: 10.4137/cmamd.s13098
Hosseini, B., Taheri, M., Pourroustaei Ardekani, R., Moradi, S., & Kazempour Mofrad, M. (2019). Periarticular hypertonic dextrose vs intraarticular hyaluronic acid injections: a comparison of two minimally invasive techniques in the treatment of symptomatic knee osteoarthritis. Open Access Rheumatology: Research and Reviews, 269-274.
Humphries, D. (2013). Embolia cutis medicamentosa after polidocanol injection of neovessels in Achilles tendinosis. Gd Rounds, 13, 12-16.
Hung, C. Y., Hsiao, M. Y., Chang, K. V., Han, D. S., & Wang, T. G. (2016). Comparative effectiveness of dextrose prolotherapy versus control injections and exercise in the management of osteoarthritis pain: a systematic review and meta-analysis. J Pain Res, 9, 847-857. doi: 10.2147/jpr.s118669
Jensen, K. T., Rabago, D. P., Best, T. M., Patterson, J. J., & Vanderby, R., Jr. (2008). Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res, 26(6), 816-823. doi: 10.1002/jor.20600
Keplinger, J. E., & Bucy, P. C. (1960). Paraplegia from treatment with sclerosing agents. Report of a case. Jama, 173, 1333-1335. doi: 10.1001/jama.1960.03020300045014
Kim, W. M., Lee, H. G., Jeong, C. W., Kim, C. M., & Yoon, M. H. (2010). A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. J Altern Complement Med, 16(12), 1285-1290. doi: 10.1089/acm.2010.0031
Maxwell, N. J., Ryan, M. B., Taunton, J. E., Gillies, J. H., & Wong, A. D. (2007). Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. AJR Am J Roentgenol, 189(4), W215-220. doi: 10.2214/ajr.06.1158
Mustafa, R., Güngörmüs, M., & Mollaoglu, N. (2018). Evaluation of the efficacy of different concentrations of dextrose prolotherapy in temporomandibular joint hypermobility treatment. Journal of Craniofacial Surgery, 29(5), e461-e465.
Ohberg, L., & Alfredson, H. (2002). Ultrasound guided sclerosis of neovessels in painful chronic Achilles tendinosis: pilot study of a new treatment. Br J Sports Med, 36(3), 173-175; discussion 176-177. doi: 10.1136/bjsm.36.3.173
Ongley, M., Dorman, T., Klein, R., Eek, B., & Hubert, L. (1987). A new approach to the treatment of chronic low back pain. The Lancet, 330(8551), 143-146.
Örsçelik, A., & Solmaz, İ. (2023). Popüler Bir Tamamlayici Tip Tedavisi: Proloterapİ. SDÜ Tıp Fakültesi Dergisi, 30(1), 135-142.
Özcan, E., & Sert, A. T. (2016). Kas iskelet ağrısı tedavisinde proloterapinin kanıta dayalı kullanımı. Turkish Journal of Physical Medicine & Rehabilitation/Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi, 62(2).
Pishgahi, A., Abolhasan, R., Shakouri, S. K., Soltani-Zangbar, M. S., Dareshiri, S., Ranjbar Kiyakalayeh, S., . . . Yousefi, M. (2020). Effect of Dextrose Prolotherapy, Platelet Rich Plasma and Autologous Conditioned Serum on Knee Osteoarthritis: A Randomized Clinical Trial. Iran J Allergy Asthma Immunol, 19(3), 243-252. doi: 10.18502/ijaai.v19i3.3452
Rabago, D., Mundt, M., Zgierska, A., & Grettie, J. (2015). Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: Long term outcomes. Complementary therapies in medicine, 23(3), 388-395.
Rabago, D., & Nourani, B. (2017). Prolotherapy for Osteoarthritis and Tendinopathy: a Descriptive Review. Curr Rheumatol Rep, 19(6), 34. doi: 10.1007/s11926-017-0659-3
Rabago, D., Patterson, J. J., Mundt, M., Kijowski, R., Grettie, J., Segal, N. A., & Zgierska, A. (2013). Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. The Annals of Family Medicine, 11(3), 229-237.
Rabago, D., Slattengren, A., & Zgierska, A. (2010). Prolotherapy in primary care practice. Prim Care, 37(1), 65-80. doi: 10.1016/j.pop.2009.09.013
Rahimzadeh, P., Imani, F., Faiz, S. H. R., Entezary, S. R., Nasiri, A. A., & Ziaeefard, M. (2014). Investigation the efficacy of intra-articular prolotherapy with erythropoietin and dextrose and intra-articular pulsed radiofrequency on pain level reduction and range of motion improvement in primary osteoarthritis of knee. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 19(8), 696.
Reeves, K. D., & Hassanein, K. (2000). Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med, 6(2), 68-74, 77-80.
Scarpone, M., Rabago, D. P., Zgierska, A., Arbogast, G., & Snell, E. (2008). The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med, 18(3), 248-254. doi: 10.1097/JSM.0b013e318170fc87
Schneider, R. C., Williams, J. J., & Liss, L. (1959). Fatality after injection of sclerosing agent to precipitate fibro-osseous proliferation. J Am Med Assoc, 170(15), 1768-1772. doi: 10.1001/jama.1959.03010150012003
Solmaz, İ., Akpancar, S., Örsçelik, A., Yener-Karasimav, Ö., & Gül, D. (2019). Dextrose injections for failed back surgery syndrome: a consecutive case series. Eur Spine J, 28(7), 1610-1617. doi: 10.1007/s00586-019-06011-3
Vijayendranath Nayak, S., Gunasheela, S., Karthik, M., & Hegde, A. (2020). Healing by Inflammation-Prolotherapy. Case Rep Dent Sci, 1(1), 9-14.
Waldman, S. D. (2011). Pain management E-book: Elsevier Health Sciences.
Waluyo, Y., Artika, S. R., Insani Nanda, W., Gunawan, A., & Zainal, A. T. F. (2023). Efficacy of Prolotherapy for Osteoarthritis: A Systematic Review. J Rehabil Med, 55, jrm00372. doi: 10.2340/jrm.v55.2572
Yelland, M. J., Glasziou, P. P., Bogduk, N., Schluter, P. J., & McKernon, M. (2004). Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial. Spine (Phila Pa 1976), 29(1), 9-16; discussion 16. doi: 10.1097/01.brs.0000105529.07222.5b
Zhu, M., Rabago, D., Chung, V. C., Reeves, K. D., Wong, S. Y., & Sit, R. W. (2022). Effects of Hypertonic Dextrose Injection (Prolotherapy) in Lateral Elbow Tendinosis: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil, 103(11), 2209-2218. doi: 10.1016/j.apmr.2022.01.166

Details

Primary Language

Turkish

Subjects

Clinical Sciences

Journal Section

Review

Authors

Hacı Ahmet Aydemir ^*
0000-0001-9656-5089
Türkiye

Publication Date

December 15, 2023

Submission Date

April 25, 2023

Acceptance Date

September 18, 2023

Published in Issue

Year 2023 Volume: 4 Number: 4

DOI

https://doi.org/10.53445/batd.1287712

IZ

https://izlik.org/JA55CJ78FW

APA

Aydemir, H. A. (2023). Proloterapinin Sekonder ve İyatrojenik Etkileri. Journal of Integrative and Anatolian Medicine, 4(4), 34-44. https://doi.org/10.53445/batd.1287712

AMA

1.Aydemir HA. Proloterapinin Sekonder ve İyatrojenik Etkileri. J. Integr. Anatol. Med. 2023;4(4):34-44. doi:10.53445/batd.1287712

Chicago

Aydemir, Hacı Ahmet. 2023. “Proloterapinin Sekonder Ve İyatrojenik Etkileri”. Journal of Integrative and Anatolian Medicine 4 (4): 34-44. https://doi.org/10.53445/batd.1287712.

EndNote

Aydemir HA (December 1, 2023) Proloterapinin Sekonder ve İyatrojenik Etkileri. Journal of Integrative and Anatolian Medicine 4 4 34–44.

IEEE

[1]H. A. Aydemir, “Proloterapinin Sekonder ve İyatrojenik Etkileri”, J. Integr. Anatol. Med., vol. 4, no. 4, pp. 34–44, Dec. 2023, doi: 10.53445/batd.1287712.

ISNAD

Aydemir, Hacı Ahmet. “Proloterapinin Sekonder Ve İyatrojenik Etkileri”. Journal of Integrative and Anatolian Medicine 4/4 (December 1, 2023): 34-44. https://doi.org/10.53445/batd.1287712.

JAMA

1.Aydemir HA. Proloterapinin Sekonder ve İyatrojenik Etkileri. J. Integr. Anatol. Med. 2023;4:34–44.

MLA

Aydemir, Hacı Ahmet. “Proloterapinin Sekonder Ve İyatrojenik Etkileri”. Journal of Integrative and Anatolian Medicine, vol. 4, no. 4, Dec. 2023, pp. 34-44, doi:10.53445/batd.1287712.

Vancouver

1.Hacı Ahmet Aydemir. Proloterapinin Sekonder ve İyatrojenik Etkileri. J. Integr. Anatol. Med. 2023 Dec. 1;4(4):34-4. doi:10.53445/batd.1287712

J. Integr. Anatol. Med. (Abbreviated Title)

◆◆◆

e-ISSN: 2687-6345

◆◆◆

This work is licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).

Proloterapinin Sekonder ve İyatrojenik Etkileri

Proloterapinin Sekonder ve İyatrojenik Etkileri

Abstract

Keywords

Secondary and Iatrogenic Effects of Prolotherapy

Abstract

Keywords

References

Details

Primary Language

Subjects

Journal Section

Authors

Publication Date

Submission Date

Acceptance Date

Published in Issue

DOI

IZ

Cite

J. Integr. Anatol. Med. (Abbreviated Title)